SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-20-005056
Filing Date
2020-03-06
Accepted
2020-03-06 16:03:16
Documents
82
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10k.htm 10-K 1505839
2 EXHIBIT 10.6.1 ex10_61.htm EX-10.6.1 49491
3 EXHIBIT 10.10 ex10_10.htm EX-10.10 16334
4 EXHIBIT 21.1 ex21_1.htm EX-21.1 4212
5 EXHIBIT 23.1 ex23_1.htm EX-23.1 2006
6 EXHIBIT 31.1 ex31_1.htm EX-31.1 12034
7 EXHIBIT 31.2 ex31_2.htm EX-31.2 12035
8 EXHIBIT 32.1 ex32_1.htm EX-32.1 6381
15 image00001.jpg GRAPHIC 2522
16 image00002.jpg GRAPHIC 26368
  Complete submission text file 0001140361-20-005056.txt   7032396

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT rckt-20191231.xml EX-101.INS 1115922
10 XBRL TAXONOMY EXTENSION SCHEMA rckt-20191231.xsd EX-101.SCH 63466
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rckt-20191231_cal.xml EX-101.CAL 66954
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rckt-20191231_def.xml EX-101.DEF 308326
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20191231_lab.xml EX-101.LAB 940109
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20191231_pre.xml EX-101.PRE 480671
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36829 | Film No.: 20694699
SIC: 2834 Pharmaceutical Preparations